Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Accumulated amortization of deferred leasing costs $ 32,379 $ 31,768
Common Shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common Shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common Shares of beneficial interest issued (in shares) 112,424,671 112,327,533
Common Shares of beneficial interest, shares outstanding (in shares) 112,424,671 112,327,533
Investing Receivables    
Investing receivable allowance for credit loss $ 1,645 $ 1,599